Ozempic Was Never Just a Weight-Loss Drug
GLP-1s are doing something far beyond weight loss and diabetes control: they appear to be modulating the immune system, with new data linking them to significantly fewer serious infections, including tuberculosis. This reframes these controversial drugs from metabolic luxury to potential broad-spectrum anti-infectives. But it exposes a brutal irony—the drug class that could fight diseases of poverty is priced like a status symbol, ensuring those most vulnerable to infection are the least likely to ever access it.